Anticipated Shortage

RETEVMO

ELI LILLY CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of RETEVMO in Canada?

A shortage of RETEVMO 40MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 16, 2026), but it has not started yet.

When will RETEVMO be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file1 product

Affected strength40MG

Last updated2026-09-16

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

RETEVMO

ELI LILLY CANADA INC

40MG · DIN 02565668

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02516918

Strength

40MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

SELPERCATINIB

See all SELPERCATINIB products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-16

Anticipated Shortage

Other (Please describe in comments)

Other Products from ELI LILLY CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

20MG · DIN 02338327

100MG · DIN 02306433

500MG · DIN 02253437

30MG · DIN 02382369

100UNIT · DIN 02461528

BASAGLAR

100UNIT · DIN 02444844